期刊文献+

阿帕替尼对胃癌细胞增殖、凋亡及VEGFR通路的影响研究 被引量:1

Effect research of apatinib on the proliferation,apoptosis and VEGFR pathway of gastric cancer cells
下载PDF
导出
摘要 目的探讨阿帕替尼对胃癌细胞增殖、凋亡及VEGFR通路的影响。方法选取胃癌细胞系HGC-27和NCI-N87细胞,通过CCK-8细胞增殖试验和克隆形成实验探讨不同浓度阿帕替尼对HGC-27和NCI-N87细胞增殖的影响;采用流式细胞术检测不同浓度阿帕替尼对HGC-27和NCI-N87细胞凋亡的影响;采用Western blot法检测不同浓度阿帕替尼对HGC-27和NCI-N87细胞凋亡相关蛋白(Bcl-2、Bax、Caspase 3、Cleaved-Caspase 3)以及血管内皮生长因子受体2(VEGFR2)表达量的影响。结果CCK-8细胞增殖试验和克隆形成实验结果显示,随着阿帕替尼浓度的增加,NCI-N87、HGC-27细胞存活率、细胞克隆数逐渐下降。流式细胞术检测结果显示,随着阿帕替尼浓度的增加,NCI-N87及HGC-27细胞凋亡率显著增加。Western blotting结果显示,随着阿帕替尼浓度的增加,NCI-N87及HGC-27细胞的Bcl-2表达水平降低,Bax、Cleaved-Caspase 3的表达水平升高;随着阿帕替尼浓度升高,NCI-N87及HGC-27细胞的VEGFR2表达水平下降。结论阿帕替尼具有抑制胃癌细胞增殖、促进其凋亡的作用,可能与其可调节凋亡相关蛋白和VEGFR通路相关蛋白的表达水平有关。 Objective To explore the effects of apatinib on the proliferation,apoptosis and the VEGFR pathway of gastric cancer cells.Methods HGC-27 and NCI-N87 cells belonged to gastric cancer cell lines were selected,and the effects of different concentrations of apatinib on the proliferation of HGC-27 and NCI-N87 cells were investigated by CCK-8 cell proliferation test and clone formation test.Flow cytometry was used to detect the effect of apatinib in different concentrations on the apoptosis of HGC-27 and NCI-N87 cells.Western blot was used to detect the effects of different concentrations of apatinib on the apoptosis-related proteins(Bcl-2,Bax,Caspase 3,Cleaved-Caspase 3)and vascular endothelial growth factor receptor 2(VEGFR2)expression of HGC-27 and NCI-N87 cells.Results The results of CCK-8 cell proliferation test and clone formation test showed that,with the increase of the apatinib concentrations,the survival rate of NCI-N87 and HGC-27 cells and the number of cell clones gradually decreased.The detective results of flow cytometry expressed that along with the increase of the concentrations of apatinib,the apoptosis rate of NCI-N87 and HGC-27 cells increased significantly.Western blot results revealed that as the concentrations of apatinib increased,the expression level of Bcl-2 decreased,whereas the expression levels of Bax and Cleaved-Caspase 3 increased,and the expression level of VEGFR2 decreased in both NCI-N87 and HGC-27 cells.Conclusion Apatinib can inhibit the proliferation of gastric cancer cells and promote apoptosis,which may be related to its ability to regulate the expression levels of apoptosis-related proteins and VEGFR pathway-related proteins.
作者 宋锦添 陈奕贵 郑亮 蔡雄超 王益 SONG Jintian;CHEN Yigui;ZHENG Liang;CAI Xiongchao;WANG Yi(Department of Abdominal Oncology,the Affiliated Cancer Hospital of Fujian Medical University&Fujian Cancer Hospital,Fuzhou 350014,Fujian province,China;Department of Abdominal Tumor Surgery,the Affiliated Cancer Hospital of Fujian Medical University&Fujian Cancer Hospital,Fuzhou 350014,Fujian province,China)
出处 《内科》 2021年第3期303-307,共5页 Internal Medicine
基金 福建省卫生健康青年科研课题(2019-1-10)。
关键词 胃癌 VEGFR通路 增殖 凋亡 阿帕替尼 Gastric cancer VEGFR pathway Proliferation Apoptosis Apatinib
  • 相关文献

参考文献2

二级参考文献12

  • 1Nawfal R Hussein.Helicobacter pylori and gastric cancer in the Middle East: A new enigma?[J].World Journal of Gastroenterology,2010,16(26):3226-3234. 被引量:3
  • 2Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J]. The Lancet . 2010 (9742) 被引量:20
  • 3Masahiro Asaka.A new approach for elimination of gastric cancer deaths in Japan[J].Int J Cancer.2012(6) 被引量:2
  • 4Xavier Calvet,María‐José Ramírez Lázaro,Philippe Lehours,Francis Mégraud.Diagnosis and Epidemiology of H elicobacter pylori Infection[J].Helicobacter.2013 被引量:5
  • 5Kamran Aryana,Mohammad Keramati,Seyed Zakavi,Mohammad Sadeghian,Hedieh Akbari.Association of Helicobacter pylori infection with the Lewis and ABO blood groups in dyspeptic patients[J].Nigerian Medical Journal.2013(3) 被引量:1
  • 6Richard Kim,Ann Tan,Minsig Choi,Bassel F. El-Rayes.Geographic differences in approach to advanced gastric cancer: Is there a standard approach?[J].Critical Reviews in Oncology / Hematology.2013 被引量:1
  • 7Ye Hu,Jing Yuan Fang,Shu Dong Xiao.Can the incidence of gastric cancer be reduced in the new century?[J].Journal of Digestive Diseases.2012(1) 被引量:2
  • 8Takeshi Matsuhisa,Hafeza Aftab.Observation of Gastric Mucosa in B angladesh, the Country with the Lowest Incidence of Gastric Cancer, and J apan, the Country with the Highest Incidence[J].Helicobacter.2012(5) 被引量:1
  • 9Ji Yeon Kim,Hye Seung Lee,Nayoung Kim,Cheol Min Shin,Sang Hyub Lee,Young Soo Park,Jin‐Hyeok Hwang,Jin‐Wook Kim,Sook‐Hyang Jeong,Dong Ho Lee,Do Joong Park,Hyung Ho Kim,Hyun Chae Jung.Prevalence and Clinicopathologic Characteristics of Gastric Cardia Cancer in South Korea[J].Helicobacter.2012(5) 被引量:1
  • 10Brigette BY Ma,Edwin P Hui,Tony SK Mok.Population-based differences in treatment outcome following anticancer drug therapies[J].Lancet Oncology.2010(1) 被引量:1

共引文献173

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部